Lisa J Schlein

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 11

Top Topics

Pluripotent Stem Cells

Inflammatory Response

Metastatic Colorectal Cancer

Top Venues

The Journal of pharmacology and experimental therapeutics

Veterinary pathology

Veterinary clinical pathology

This page only lists publications with an associated author ORCID identifier.

Publications

Lisa J Schlein, Samuel A Brill, Rachel V Brady, Kristen B Farrell, Barbara J Rose, Travis K Meuten, Craig T Jordan, Douglas H Thamm
Parthenolide As a Therapeutic for Disseminated Canine Neoplasms. The Journal of pharmacology and experimental therapeutics 388 (3) (2024)
Lisa J Schlein, Samuel A Brill, Rachel V Brady, Kristen B Farrell, Barbara J Rose, Travis K Meuten, Craig T Jordan, Douglas H Thamm
Parthenolide As a Therapeutic for Disseminated Canine Neoplasms. The Journal of pharmacology and experimental therapeutics 388 (3) (2024)
Lisa J Schlein, Samuel A Brill, Rachel V Brady, Kristen B Farrell, Barbara J Rose, Travis K Meuten, Craig T Jordan, Douglas H Thamm
Parthenolide As a Therapeutic for Disseminated Canine Neoplasms. The Journal of pharmacology and experimental therapeutics 388 (3) (2024)
Lisa J Schlein, Samuel A Brill, Rachel V Brady, Kristen B Farrell, Barbara J Rose, Travis K Meuten, Craig T Jordan, Douglas H Thamm
Parthenolide As a Therapeutic for Disseminated Canine Neoplasms. The Journal of pharmacology and experimental therapeutics 388 (3) (2024)
Lisa J Schlein, Samuel A Brill, Rachel V Brady, Kristen B Farrell, Barbara J Rose, Travis K Meuten, Craig T Jordan, Douglas H Thamm
Parthenolide As a Therapeutic for Disseminated Canine Neoplasms. The Journal of pharmacology and experimental therapeutics 388 (3) (2024)
Lisa J Schlein, Samuel A Brill, Rachel V Brady, Kristen B Farrell, Barbara J Rose, Travis K Meuten, Craig T Jordan, Douglas H Thamm
Parthenolide As a Therapeutic for Disseminated Canine Neoplasms. The Journal of pharmacology and experimental therapeutics 388 (3) (2024)
Lisa J Schlein, Samuel A Brill, Rachel V Brady, Kristen B Farrell, Barbara J Rose, Travis K Meuten, Craig T Jordan, Douglas H Thamm
Parthenolide As a Therapeutic for Disseminated Canine Neoplasms. The Journal of pharmacology and experimental therapeutics 388 (3) (2024)
Claire Quinn, Kayla Harding, Lisa J Schlein, Jérémie Korchia, Laura L Coffee, Amy L MacNeill, Katherine Tucker-Mohl, Dawn L Duval, Laura E Brandt
It's not always histiocytic sarcoma: Immunocytochemistry to identify two unusual tumors in a Bernese Mountain dog. Veterinary clinical pathology (2024)
Lisa J Schlein, Douglas H Thamm
Immunohistochemical evidence of NF-kB activation in canine lymphomas, histiocytic sarcomas, hemangiosarcomas, and mast cell tumors. Veterinary pathology (2023)
Lisa J Schlein, Samuel Brill, Rachel Brady, Kristen B Farrell, Barbara J Rose, Travis Meuten, Craig T Jordan, Douglas H Thamm
Parthenolide as a therapeutic for disseminated canine neoplasms . The Journal of pharmacology and experimental therapeutics (2023)
Lisa J Schlein, Douglas H Thamm
Review: NF-kB activation in canine cancer. Veterinary pathology 59 (5) (2022)